Production (Stage)
HCA Healthcare, Inc.
HCA
$376.59
-$0.05-0.01%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.30% | 8.67% | 10.23% | 10.38% | 9.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.30% | 8.67% | 10.23% | 10.38% | 9.59% |
| Cost of Revenue | 5.09% | 6.44% | 6.84% | 7.53% | 7.93% |
| Gross Profit | 10.66% | 12.12% | 15.58% | 14.89% | 12.22% |
| SG&A Expenses | 5.53% | 5.53% | 1.84% | 1.84% | 1.84% |
| Depreciation & Amortization | 8.38% | 7.64% | 6.81% | 5.10% | 4.11% |
| Other Operating Expenses | 11.24% | 15.89% | 20.75% | 23.46% | 22.02% |
| Total Operating Expenses | 6.63% | 8.52% | 9.64% | 10.51% | 10.41% |
| Operating Income | 11.18% | 9.57% | 13.66% | 9.61% | 5.02% |
| Income Before Tax | 7.12% | 10.60% | 0.83% | -3.18% | -7.56% |
| Income Tax Expenses | 14.40% | 15.54% | 6.49% | 2.34% | -5.35% |
| Earnings from Continuing Operations | 5.20% | 9.29% | -0.64% | -4.61% | -8.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.39% | -5.65% | 22.16% | 24.45% | 25.36% |
| Net Income | 5.65% | 9.88% | 3.73% | -0.57% | -4.59% |
| EBIT | 11.18% | 9.57% | 13.66% | 9.61% | 5.02% |
| EBITDA | 10.50% | 9.10% | 11.97% | 8.51% | 4.80% |
| EPS Basic | 11.97% | 15.73% | 9.50% | 4.86% | 0.73% |
| Normalized Basic EPS | 21.51% | 17.42% | 35.08% | 29.02% | 20.68% |
| EPS Diluted | 12.15% | 15.79% | 9.53% | 4.76% | 0.59% |
| Normalized Diluted EPS | 21.72% | 17.56% | 35.45% | 29.25% | 20.80% |
| Average Basic Shares Outstanding | -5.65% | -5.13% | -4.94% | -4.90% | -5.24% |
| Average Diluted Shares Outstanding | -5.86% | -5.29% | -5.09% | -4.93% | -5.18% |
| Dividend Per Share | 9.76% | 10.00% | 9.32% | 8.62% | 7.89% |
| Payout Ratio | -0.03% | -0.05% | 0.01% | 0.04% | 0.08% |